Connection

CHRIS AMOS to Age Factors

This is a "connection" page, showing publications CHRIS AMOS has written about Age Factors.
Connection Strength

0.485
  1. The shared genetic architecture between epidemiological and behavioral traits with lung cancer. Sci Rep. 2021 09 02; 11(1):17559.
    View in: PubMed
    Score: 0.112
  2. Imprinting detection by extending a regression-based QTL analysis method. Hum Genet. 2007 Sep; 122(2):159-74.
    View in: PubMed
    Score: 0.042
  3. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Res. 2022 01 15; 82(2):199-209.
    View in: PubMed
    Score: 0.028
  4. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res. 2001 Feb 15; 61(4):1269-71.
    View in: PubMed
    Score: 0.027
  5. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 2021 03 15; 81(6):1607-1615.
    View in: PubMed
    Score: 0.027
  6. Modeling age x major gene interaction by a variance component approach. Genet Epidemiol. 2001; 21 Suppl 1:S849-53.
    View in: PubMed
    Score: 0.027
  7. Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age. Int J Cancer. 2018 11 15; 143(10):2359-2366.
    View in: PubMed
    Score: 0.023
  8. Assessing genetic linkage and association with robust components of variance approaches. Ann Hum Genet. 1996 03; 60(2):143-60.
    View in: PubMed
    Score: 0.019
  9. Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less. Breast. 2014 Dec; 23(6):770-4.
    View in: PubMed
    Score: 0.017
  10. Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S49-50.
    View in: PubMed
    Score: 0.016
  11. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer. 2013 Apr; 49(6):1335-45.
    View in: PubMed
    Score: 0.015
  12. Age at onset for familial epithelial ovarian cancer. JAMA. 1992 Oct 14; 268(14):1896-9.
    View in: PubMed
    Score: 0.015
  13. Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers. Hum Genet. 2011 Dec; 130(6):789-94.
    View in: PubMed
    Score: 0.014
  14. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Mol Carcinog. 2012 May; 51(5):433-8.
    View in: PubMed
    Score: 0.014
  15. Familiality of breast cancer and socioeconomic status in blacks. Cancer Res. 1991 Apr 01; 51(7):1793-7.
    View in: PubMed
    Score: 0.014
  16. Segregation analysis of breast cancer from the cancer and steroid hormone study: histologic subtypes. J Natl Cancer Inst. 1990 Dec 19; 82(24):1911-7.
    View in: PubMed
    Score: 0.013
  17. Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clin Cancer Res. 2007 May 15; 13(10):3100-4.
    View in: PubMed
    Score: 0.010
  18. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):886-91.
    View in: PubMed
    Score: 0.010
  19. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006 Feb 20; 24(6):863-71.
    View in: PubMed
    Score: 0.010
  20. GSTM1 polymorphism does not affect hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):676-8.
    View in: PubMed
    Score: 0.008
  21. Genetic linkage and imprinting effects on body mass index in children and young adults. Eur J Hum Genet. 2003 Jun; 11(6):425-32.
    View in: PubMed
    Score: 0.008
  22. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000 Nov 01; 92(21):1764-72.
    View in: PubMed
    Score: 0.007
  23. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20; 89(3):259-64.
    View in: PubMed
    Score: 0.006
  24. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):99-103.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.